Photon-counting CT (PCCT) represents a transformative advancement in cardiac imaging, addressing key limitations of ...

Bristol-Myers Squibb’s PD-1 drug Opdivo (nivolumab) and MSD’s rival Keytruda (pembrolizumab) are approved with chemotherapy for first-line use in upper GI cancers, with the former cleared for ...

J Gastroenterol Hepatol. 2005;20(1):11-25.